0001209191-16-142199.txt : 20160920 0001209191-16-142199.hdr.sgml : 20160920 20160920201045 ACCESSION NUMBER: 0001209191-16-142199 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160920 FILED AS OF DATE: 20160920 DATE AS OF CHANGE: 20160920 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immune Design Corp. CENTRAL INDEX KEY: 0001437786 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262007174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1616 EASTLAKE AVE. E STREET 2: SUITE 310 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 682-0645 MAIL ADDRESS: STREET 1: 1616 EASTLAKE AVE. E STREET 2: SUITE 310 CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: VACCSYS INC DATE OF NAME CHANGE: 20080617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Svennilson Peter CENTRAL INDEX KEY: 0001606074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36561 FILM NUMBER: 161894769 MAIL ADDRESS: STREET 1: C/O IMMUNE DESIGN CORP. STREET 2: 1616 EASTLAKE AVE. E, SUITE 310 CITY: SEATTLE STATE: WA ZIP: 98102 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-09-20 0 0001437786 Immune Design Corp. IMDZ 0001606074 Svennilson Peter C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVENUE. E., SUITE 310 SEATTLE WA 98102 1 0 1 0 Common Stock 2016-09-20 4 P 0 800000 6.25 A 800000 I See Footnote Common Stock 3161942 I See Footnote The securities are directly held by The Column Group II, LP ("The Column Group II") and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of The Column Group II. TCG II GP has voting and dispositive power with respect to the shares owned by The Column Group II. Mr. Svennilson is a managing partner of TCG II GP and may be deemed to have shared voting and dispositive power over the shares owned by The Column Group II. Mr. Svennilson disclaims beneficial ownership of all shares held by The Column Group II, except to the extent of his actual pecuniary interest therein. The securities are directly held by The Column Group, LP ("The Column Group") and indirectly held by The Column Group GP, LP ("TCG GP"), the general partner of The Column Group. TCG GP has voting and dispositive power with respect to the shares owned by The Column Group. Mr. Svennilson is a managing partner of TCG GP and may be deemed to have shared voting and dispositive power over the shares owned by The Column Group. Mr. Svennilson disclaims beneficial ownership of all shares held by The Column Group, except to the extent of his actual pecuniary interest therein. /s/ Laura A. Berezin, Attorney-In-Fact 2016-09-20